As synthetic biology and mRNA-based therapeutics continue to accelerate, the need for clean, efficient, and scalable in vitro transcription (IVT) systems has never been greater. A key factor in the success of IVT reactions is the choice of enzymes — and even more critical is how they work together. That’s why Hzymes Biotech has developed a versatile, high-performance Enzyme Mix series to support next-generation mRNA production, enzyme-based capping, and co-transcription capping systems.

What Is Enzyme Mix?

An Enzyme Mix is a pre-formulated blend of key enzymes used for synthesizing high-quality mRNA in IVT systems. Hzymes’ mixes combine:

• T7 RNA Polymerase variants (including M6, thermostable, and low/trace dsRNA types)
• RNase Inhibitor to protect RNA integrity
• Yeast Inorganic Pyrophosphatase to remove inhibitory pyrophosphate byproducts

These components work synergistically to improve transcription efficiency, simplify workflows, and reduce variability between batches — all while ensuring the lowest possible contamination risk.

Explore the Hzymes Enzyme Mix Portfolio

🔹 Enzyme Mix (Standard)

• Composition: T7 RNA Polymerase (M6), RNase Inhibitor, Yeast Pyrophosphatase
• Application: Ideal for enzyme-based capping systems
• Benefit: Balanced activity for efficient transcription and capped RNA production.

🔹 Enzyme Mix 2.0

• Composition: Same core components as the standard mix.
• Application: Optimized for co-transcriptional capping systems
• Benefit: Supports precise cap analog incorporation during transcription.

🔹 Enzyme Mix (Low dsRNA)

• Special Feature: Formulated to significantly reduce double-stranded RNA (dsRNA) byproducts.
• Application: For sensitive applications including therapeutic mRNA.
• Benefit: Enhanced purity and safety of RNA products.

🔹 Enzyme Mix (Thermostable)

• Composition: Thermostable T7 RNA Polymerase + RNase Inhibitor + Yeast Pyrophosphatase
• Application: Suitable for both enzyme-based and co-transcription capping
• Benefit: Higher reaction temperatures improve template activity and yield.

🔹 Enzyme Mix (Trace dsRNA)

• Feature: Contains engineered T7 RNA Polymerase to produce ultra-pure RNA with trace dsRNA levels.
• Application: Clinical-grade mRNA production and regulatory-sensitive pipelines.
• Benefit: Meets the purity demands for GMP workflows and vaccine development.

Why Choose Hzymes Enzyme Mixes?

• ✅ High Transcription Efficiency: Optimized enzyme synergy increases yield.
• ✅ Low dsRNA Contamination: Supports safety and downstream applications.
• ✅ Batch Consistency: Reliable performance across production lots.
• ✅ Convenient Use: Ready-to-use formulation reduces prep time and error.
• ✅ Flexible Compatibility: Suitable for both standard and advanced capping strategies.

Applications Across Synthetic Biology and Biopharma

Hzymes' Enzyme Mix products are designed to meet the demands of cutting-edge applications:

• mRNA vaccine and therapeutic development
• Gene editing and CRISPR workflows
• In vitro transcription for synthetic RNA
• Cell therapy and immunotherapy
• Research-scale and GMP-grade manufacturing

Engineered for Performance: Backed by Hzymes R&D

As a global innovator in enzyme technology, Hzymes Biotech combines proprietary enzyme engineering with rigorous quality control. Our R&D team works directly with partners to optimize enzyme solutions tailored to specific mRNA production challenges.

Conclusion

Hzymes’ Enzyme Mix series offers a complete solution for high-quality mRNA synthesis, from research labs to large-scale manufacturing. Whether you're optimizing yield, improving capping efficiency, or ensuring clinical-grade purity, we have a mix that meets your needs.